SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hepion Pharmaceuticals, Inc. – ‘8-K’ for 3/5/24

On:  Wednesday, 3/6/24, at 4:15pm ET   ·   For:  3/5/24   ·   Accession #:  1493152-24-9028   ·   File #:  1-36856

Previous ‘8-K’:  ‘8-K’ on / for 2/20/24   ·   Latest ‘8-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/06/24  Hepion Pharmaceuticals, Inc.      8-K:5       3/05/24   10:196K                                   M2 Compliance LLC/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     34K 
 5: R1          Cover                                               HTML     49K 
 7: XML         IDEA XML File -- Filing Summary                      XML     11K 
10: XML         XBRL Instance -- form8-k_htm                         XML     16K 
 6: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- hepa-20240305_lab                     XML     96K 
 4: EX-101.PRE  XBRL Presentations -- hepa-20240305_pre              XML     64K 
 2: EX-101.SCH  XBRL Schema -- hepa-20240305                         XSD     12K 
 8: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    34K 
 9: ZIP         XBRL Zipped Folder -- 0001493152-24-009028-xbrl      Zip     14K 




        
Filing Submission 0001493152-24-009028 – SGML Text

Original SGML Text submitted by:  M2 Compliance LLC/FA  (as Filing Agent) 

Show all <DOCUMENT> <TEXT> elements below – 196K                        Top    Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20240306-161627	 Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20240306-161559	 Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20240306-161523	 Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001493152-24-009028
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		12
<PERIOD>			20240305
<ITEMS>				5.02
<FILING-DATE>			20240306
<DATE-OF-FILING-DATE-CHANGE>	20240306
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Hepion Pharmaceuticals, Inc.
<CIK>				0001583771
<ASSIGNED-SIC>			2834
<ORGANIZATION-NAME>		03 Life Sciences
<IRS-NUMBER>			462783806  46-2783806
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-36856
<FILM-NUMBER>			24726055
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			399 THORNALL STREET
<STREET2>			FIRST FLOOR
<CITY>				EDISON
<STATE>				NJ
<ZIP>				08837
<PHONE>				732-902-4000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			399 THORNALL STREET
<STREET2>			FIRST FLOOR
<CITY>				EDISON
<STATE>				NJ
<ZIP>				08837
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		ContraVir Pharmaceuticals, Inc.
<DATE-CHANGED>			20130806
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:HEPA="http://hepionpharma.com/20240305">
       Show <XBRL>: 309 lines (widest: 863 characters) - 34K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-101.SCH
<SEQUENCE>	2
<FILENAME>	hepa-20240305.xsd
<DESCRIPTION>	XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
       Show <XBRL>: 30 lines (widest: 573 characters) - 3K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-101.LAB
<SEQUENCE>	3
<FILENAME>	hepa-20240305_lab.xml
<DESCRIPTION>	XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 194 lines (widest: 316 characters) - 34K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-101.PRE
<SEQUENCE>	4
<FILENAME>	hepa-20240305_pre.xml
<DESCRIPTION>	XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 128 lines (widest: 316 characters) - 22K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	5
<FILENAME>	R1.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 875 lines (widest: 387 characters) - 41K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EXCEL
<SEQUENCE>	7  6  Document/Exhibit 6
<FILENAME>	Financial_Report.xlsx
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 131 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	8  7  Not a Document/Exhibit
<FILENAME>	Show.js
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 5 lines (widest: 296 characters) - 973 bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	9  8  Not a Document/Exhibit
<FILENAME>	report.css
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 182 lines (widest: 57 characters) - 4K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	11  9  Document/Exhibit 7
<FILENAME>	FilingSummary.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
       Show <XML>: 48 lines (widest: 98 characters) - 2K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		JSON
<SEQUENCE>	13  10  Document/Exhibit 8
<FILENAME>	MetaLinks.json
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 1,345 lines (widest: 520 characters) - 39K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		ZIP
<SEQUENCE>	14  11  Document/Exhibit 9
<FILENAME>	0001493152-24-009028-xbrl.zip
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 231 lines (Unix-to-Unix encoding) - 14K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	15  12  Document/Exhibit 10
<FILENAME>	form8-k_htm.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
       Show <XML>: 60 lines (widest: 130 characters) - 4K bytes  
</TEXT>
</DOCUMENT>
</SUBMISSION>
Top

Filing Submission 0001493152-24-009028   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 10:46:06.5pm ET